Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
Recruiting
Observational Study
Neuromuscular Blockade
Anesthesia, General
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 199 (estimated)
- Sponsor
- Ankara University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
It is known that deep neuromuscular block improves surgical conditions, especially during laparoscopic abdominal surgery. Based on this, in the Perioperative Neuromuscular Blockade Management guide published by the ESAIC association in 2022, it is recommended to deepen the level of neuromuscular blockade in cases where surgical conditions need to be improved. Sugammadex should be used to quickly a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: 18 - 65 (not including 65)
* BMI: 18.5-24.9
Exclusion Criteria:
* Liver and kidney disease
* Non-consenting
* Emergency surgeries
* Muscle disease
* Allergy to rocuronium and sugammadex
* Patients predicted to have difficult mask ventilation or difficult intubation
* Pr…
Contacts